Managing Director, SynGenis Pty Ltd
| Role | Organisation | Sources |
|---|---|---|
| Managing Director | SynGenis Pty Ltd | Dealroom (23 Sep 2026), becomerichfaster.com, SMH Business, Dealroom (13 Jul 2026) |
Stories naming Thomas Hanly. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
A new precision-medicine company formed by Perth's Syngenis Labs, a research institute and two scientists has bought Gene S, maker of the Rosa pharmacogenomics tool; no price was disclosed.
SynGenis, a Perth biotech, has raised A$4 million in an oversubscribed pre-seed round arranged through Euroz Hartleys, to build an AI platform for RNA and DNA medicines ahead of a planned stock listing.